Who owns Celldex Therapeutics?

Top Holders and Investors of CLDX Stock

Find out what company owns Celldex Therapeutics, who bought CLDX this quarter, and who sold shares of CLDX stock?

Fund or Company Name Number of Shares Valued At As Of
Meditor 420846 $896401 Sep 2019
Benchmark Capital Advisors 32600 $5868 Dec 2018
Horizon Kinetics 26335 $0 Dec 2018

Who sold Celldex Therapeutics?

Fund Name Date Sold Shares Held Valued At
KLP Enterprises Dec. 31, 2018 6.87M $1.37M
UBS Group AG Dec. 31, 2018 68194 $21822